Robeco Institutional Asset Management B.V. decreased its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 66.6% in the 3rd quarter, according to its most ...
The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the ...
In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Voyager Therapeutics (VYGR – Research Report). The ...
The company’s shares opened today at $17.38. Lee covers the Healthcare sector, focusing on stocks such as Argenx Se, Corcept Therapeutics, and Viking Therapeutics. According to TipRanks, Lee has an ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Zacks.com on MSN6dOpinion
5 Small Drug Stocks to Buy as Trump Gets Re-ElectedThe drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic ...
Shares are now extended from that entry. Samsara will report its third-quarter results on Dec. 5. Corcept Therapeutics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback